Last 19 quarters of trend data · Technology · Bitcoin Miners
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.55 | — | — | — | — | — | — | — | — | — | — | — | — | — | 3166.67 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.41 | 0.17 | 1.02 | 1.62 | 5.69 | 1.18 | 12.07 | 123.45 | — | 1029.64 | 487.23 | 360.55 | 342.40 | 472.94 | 525.19 | 694.52 | 1110.24 | — | — | — |
| — | -85.4% | -91.5% | -98.7% | — | -99.9% | -97.5% | -65.8% | — | +117.7% | -7.2% | -48.1% | -69.2% | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -791.0% | -27.9% | -76.9% | -143.3% | -93.9% | -107.6% | -152.9% | -225.4% | — | -114.0% | -50.8% | -33.9% | -28.6% | -31.6% | -13.4% | -9.3% | -33.4% | — | — | — |
| — | +74.0% | +49.7% | +36.4% | — | +5.6% | -201.0% | -564.0% | — | -261.3% | -279.8% | -263.5% | +14.4% | — | — | — | — | — | — | — | |
| ROA | -180.6% | -18.2% | -19.3% | -37.3% | -51.9% | -68.5% | -78.1% | -100.5% | -217.1% | -53.7% | -32.3% | -24.6% | -22.1% | -22.7% | -10.2% | -8.3% | -21.3% | -164.6% | -113.3% | -70.4% |
| — | +73.5% | +75.3% | +62.9% | +76.1% | -27.7% | -141.6% | -308.4% | -881.5% | -136.8% | -216.6% | -195.6% | -3.8% | +86.2% | +91.0% | +88.2% | — | — | — | — | |
| ROIC | -845.1% | -27.2% | -71.9% | -197.3% | — | — | — | — | -1295.2% | -56.9% | -39.8% | -36.6% | -48.4% | -61.7% | -178.3% | -835.4% | — | — | — | — |
| — | — | — | — | — | — | — | — | -2578.5% | +7.8% | +77.7% | +95.6% | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.10 | 0.01 | 0.06 | 0.10 | 0.48 | 0.20 | 0.34 | 1.65 | — | 1.44 | 0.47 | 0.27 | 0.17 | 0.11 | 0.22 | 0.10 | 0.10 | — | — | — |
| — | -94.9% | -81.0% | -93.8% | — | -86.3% | -27.7% | +517.0% | — | +1179.4% | +106.8% | +175.2% | +72.5% | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.06 | 0.11 | 0.30 | 0.06 | 1.66 | 3.07 | 2.78 | 1.44 | 0.22 | 1.79 | 2.96 | 5.37 | 8.63 | 17.10 | 7.47 | 8.79 | 9.57 | 0.03 | 0.18 | 0.23 |
| — | -96.3% | -89.3% | -95.6% | +663.2% | +70.9% | -6.0% | -73.1% | -97.5% | -89.5% | -60.4% | -39.0% | -9.8% | +65526.0% | +4030.2% | +3725.5% | — | — | — | — | |
| Quick Ratio | 0.06 | 0.11 | 0.30 | 0.06 | 1.66 | 3.07 | 2.78 | 1.44 | 0.22 | 1.79 | 2.96 | 5.37 | 8.63 | 17.10 | 7.47 | 8.79 | 9.57 | 0.03 | 0.18 | 0.23 |
| — | -96.3% | -89.3% | -95.6% | +663.2% | +70.9% | -6.0% | -73.1% | -97.5% | -89.5% | -60.4% | -39.0% | -9.8% | +65526.0% | +4030.2% | +3725.5% | — | — | — | — | |
| Interest Coverage | -164.49 | — | -176.57 | -142.27 | -123.17 | -169.47 | -254.91 | -9.04 | -12.88 | -3.72 | -2.48 | -2.08 | -1.88 | -1.98 | -0.62 | -73.19 | -0.61 | -2.22 | -3.37 | -23.57 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 19 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SHPH stock.
Shuttle Pharmaceuticals Holdings, Inc.'s current P/E is -0.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Shuttle Pharmaceuticals Holdings, Inc.'s business trajectory between earnings reports.